Gilead Sciences Inc

GILDNASDAQUSD
125.66 USD
0.79 (0.63%)🟢LIVE (AS OF 02:41 PM EDT)
🟢Market: OPEN

Gilead Sciences Inc (GILD) trades at $125.66 per share. The stock presents a mixed profile: our models indicate a Strong Buy for underlying fundamentals, while technical indicators flash a Sell. Notable factors include a robust Altman Z-Score, a strong Piotroski F-Score of 7/9, exceptional Return on Equity (39.2%) and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 22, 2026.

Open?$126.63
High?$126.63
Low?$124.46
Prev. Close?$124.87
Volume?3.4M
Avg. Volume?8.0M
VWAP?$125.80
Rel. Volume?0.42x
Bid / Ask
Bid?$125.66 × 100
Ask?$130.80 × 100
Spread?$5.14
Midpoint?$128.23
Valuation & Ratios
Market Cap?155.0B
Shares Out?1.2B
Float?1.2B
Float %?99.7%
P/E Ratio?16.82
P/B Ratio?6.59
EPS?$7.42
Dividend?2.60%
Ex-Dividend?N/A
News
Profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Employees
17.0K
Market Cap
153.7B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1992-01-22
Address
333 LAKESIDE DR
FOSTER CITY, CA 94404
Phone: (650) 574-3000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Buy
Strong SellNeutralStrong Buy
F-Score?
88
Z-Score?
96
Momentum?
83
Short Sent.?
73
Piotroski F-Score?7/9Strong
Altman Z-Score?4.52Safe
Confidence?80%High
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?2.08%Low
Short Interest?25.7M
Days to Cover?3.8
Free Float1.2B
Avg Daily Volume6.7M
Settlement Date2026-05-29
Financial Health
Current Ratio?1.97Adequate
Quick Ratio?1.77Adequate
Cash Ratio?0.80Adequate
Debt/Equity?0.94Moderate
ValuationATTRACTIVELY VALUEDvs 9 peers + S&P 500
Score
83/100
P/E?
Peers
88
S&P
75
16.8CHEAP
P/B?
Peers
22
S&P
28
6.59FAIR
P/S?
Peers
60
S&P
28
5.21FAIR
P/FCF?
Peers
88
S&P
74
15.2CHEAP
EV/EBITDA?
Peers
88
S&P
70
11.6CHEAP
EV/Sales?
Peers
70
S&P
30
5.70FAIR
Returns & Efficiency
ROE?
Peers
86
S&P
87
39.2%STRONG
ROA?
Peers
88
S&P
90
16.4%STRONG
Cash Flow & Enterprise
FCF?$10.2B
Enterprise Value?$169.6B
Fundamentals ratios updated end of day